ProductsBack/InVivoMAb anti-rat CD8alpha

InVivoMAb anti-rat CD8alpha

Name: InVivoMAb anti-rat CD8alpha
SKU: BE0415_B56
Availability: BackOrder

BE0415

ApplicationsFlow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Other Application

Product group Antibodies

Overview

Supplier
Bio X Cell
Product Name
InVivoMAb anti-rat CD8alpha
Delivery Days Customer
7
Applications
Flow Cytometry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin, Other Application
Certification
Research Use Only
Clonality
Monoclonal
Clone ID
OX-8
Concentration
4-11 mg/ml
Estimated Purity
>95%
Host
Mouse
Isotype
IgG1
Reactivity Supplier
Rat
Storage Instruction
2°C to 8°C
UNSPSC
12352203

Hartlage AS, Murthy S, Kumar A, et al. Vaccination to prevent T cell subversion can protect against persistent hepacivirus infection. Nat Commun. 2019,10(1):1113. doi: 10.1038/s41467-019-09105-0
Read this paper
Shibata S, Shinozaki N, Suganami A, et al. Photo-immune therapy with liposomally formulated phospholipid-conjugated indocyanine green induces specific antitumor responses with heat shock protein-70 expression in a glioblastoma model. Oncotarget. 2019,10(2):175-183. doi: 10.18632/oncotarget.26544
Read this paper
Nuccitelli R, Berridge JC, Mallon Z, et al. Nanoelectroablation of Murine Tumors Triggers a CD8-Dependent Inhibition of Secondary Tumor Growth. PLoS One. 2015,10(7):e0134364. doi: 10.1371/journal.pone.0134364
Read this paper
Wallgren AC, Karlsson-Parra A, Korsgren O. The main infiltrating cell in xenograft rejection is a CD4+ macrophage and not a T lymphocyte. Transplantation. 1995,60(6):594-601.
Read this paper